GOUT CHRONIC
Clinical trials for GOUT CHRONIC explained in plain language.
Never miss a new study
Get alerted when new GOUT CHRONIC trials appear
Sign up with your email to follow new studies for GOUT CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough gout: drug combo targets uric acid after other treatments fail
Disease control OngoingThis study tests a new drug called AR882, taken with a standard gout medication (XOI), in 15 people with severe, uncontrolled gout who have already failed uricase therapy. The goal is to see if the combination can lower uric acid levels and shrink painful uric acid crystal deposi…
Matched conditions: GOUT CHRONIC
Phase: PHASE2 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New gout drug shows promise in major trial
Disease control OngoingThis study tests a new medicine called AR882 to see if it can lower uric acid levels in people with gout. About 750 adults with gout will receive either AR882 or a placebo for 12 months. The main goal is to see if AR882 helps more patients reach a safe uric acid level and reduce …
Matched conditions: GOUT CHRONIC
Phase: PHASE3 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC